Compound ID | 2878
Synonym(s): Panaecin
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Pseudomonas aeruginosa |
| Description: | Synthetic compound; not cytotoxic to mammalian cells; designed to be administered via inhalation for cystic fibrosis patients; metal-based antimicrobial |
| Institute where first reported: | Aridis |
| Year first mentioned: | 2011 |
| Highest developmental phase: | Phase 2 (NCT0366614) |
| Development status: | Active as of 2024 |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/34058 |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232821/pdf/zac5568.pdf |